These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 153333)

  • 21. Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris.
    Liu PF; Hsieh YD; Lin YC; Two A; Shu CW; Huang CM
    Curr Drug Metab; 2015; 16(4):245-54. PubMed ID: 26264195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunobiology of acne. A polyvalent proprionibacteria vaccine.
    Goldman L; Michael JG; Riebel S
    Cutis; 1979 Feb; 23(2):181-4. PubMed ID: 154393
    [No Abstract]   [Full Text] [Related]  

  • 23. Oxygen and serum complement in phagocytosis and killing of Propionibacterium acnes.
    Thore M; Löfgren S; Tärnvik A
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):95-100. PubMed ID: 6880750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differentiation of various Propionibacterium species from acne-vulgaris efflorescences].
    Lentze I; Ko HL; Höffler U
    Hautarzt; 1979 May; 30(5):242-7. PubMed ID: 156167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against extractable components from Propionibacterium acnes in humans with and without acne vulgaris.
    Dalen A; Hellgren L; Iversen OJ; Vincent J
    Arch Dermatol Res; 1980; 269(3):253-9. PubMed ID: 6453560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of hyaluronidase by propionibacteria from different origins.
    Höffler U
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):123-9. PubMed ID: 44604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of neutrophil chemotactic factor production in comedonal bacteria by subminimal inhibitory concentrations of erythromycin.
    Akamatsu H; Kurokawa I; Nishijima S; Asada Y
    Dermatology; 1992; 185(1):41-3. PubMed ID: 1386264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody titers to Propionibacterium acnes cell wall carbohydrate in nodulocystic acne patients.
    Webster GF; Indrisano JP; Leyden JJ
    J Invest Dermatol; 1985 Jun; 84(6):496-500. PubMed ID: 3158714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Is acne caused by colonization with the "wrong" strain of Propionibacterium acnes? A review of the role of Propionibacterium acnes in acne].
    Lomholt HB; Kilian M
    Ugeskr Laeger; 2008 Apr; 170(15):1234-7. PubMed ID: 18433578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acne from an immunological perspective.
    Puhvel SM
    Cutis; 1976 Mar; 17(3):502-6. PubMed ID: 138543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte transformation in subjects with nodulo cystic acne.
    Puhvel SM; Amirian D; Weintraub J; Reisner RM
    Br J Dermatol; 1977 Aug; 97(2):205-11. PubMed ID: 143951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porphyrin Production and Regulation in Cutaneous Propionibacteria.
    Barnard E; Johnson T; Ngo T; Arora U; Leuterio G; McDowell A; Li H
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31941813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolution of inflammatory acne vulgaris may involve regulation of CD4+ T-cell responses to Propionibacterium acnes.
    Wilcox HE; Farrar MD; Cunliffe WJ; Holland KT; Ingham E
    Br J Dermatol; 2007 Mar; 156(3):460-5. PubMed ID: 17300234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro blastogenic response of lymphocytes in acne vulgaris (II) fusing as mitogens isolated from Propionibacterium acnes].
    Vignale RA; Lasalvia E; Paciel J
    Med Cutan Ibero Lat Am; 1977; 5(6):429-31. PubMed ID: 153993
    [No Abstract]   [Full Text] [Related]  

  • 35. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris.
    Ashbee HR; Muir SR; Cunliffe WJ; Ingham E
    Br J Dermatol; 1997 May; 136(5):730-3. PubMed ID: 9205507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for diversity within Propionibacterium acnes: a comparison of the T-cell stimulatory activity of isolates from inflammatory acne, endocarditis and the laboratory.
    Jappe U; Boit R; Farrar MD; Ingham E; Sandoe J; Holland KT
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):450-4. PubMed ID: 15196160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acne-like chronic inflammatory activity of Propionibacterium acnes preparations in an animal model: correlation with ability to stimulate the reticuloendothelial system.
    De Young LM; Spires DA; Ballaron SJ; Cummins CS; Young JM; Allison AC
    J Invest Dermatol; 1985 Sep; 85(3):255-8. PubMed ID: 3161957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular immunity to P. acnes in the normal population and patients with acne vulgaris.
    Gowland G; Ward RM; Holland KT; Cunliffe WJ
    Br J Dermatol; 1978 Jul; 99(1):43-7. PubMed ID: 150284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
    Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
    Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses.
    Kim J
    Dermatology; 2005; 211(3):193-8. PubMed ID: 16205063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.